Results 81 to 90 of about 215,426 (163)

Computed tomography guided needle biopsy: experience from 1,300 procedures

open access: yesSão Paulo Medical Journal
CONTEXT AND OBJECTIVE: Computed tomography (CT) guided biopsy is widely accepted as effective and safe for diagnosis in many settings. Accuracy depends on target organ and needle type. Cutting needles present advantages over fine needles.
Rubens Chojniak   +5 more
doaj   +1 more source

Ultrasound-guided Percutaneous Trucut Needle Biopsy for Musculoskeletal Tumours [PDF]

open access: yesMalaysian Orthopaedic Journal, 2008
PURPOSE: To evaluate the usefulness of ultrasound guidance in percutaneous needle biopsy for musculoskeletal tumours. METHODS: Forty-five consecutive patients underwent ultrasound-guided needle biopsy.
A Sallehuddin   +3 more
doaj  

Diagnostic Ability of Endoscopic Ultrasound-Guided Tissue Acquisition Using 19-Gauge Fine-Needle Biopsy Needle for Abdominal Lesions. [PDF]

open access: yesDiagnostics (Basel), 2023
Takeshita K   +22 more
europepmc   +1 more source

Multicentric B-cell lymphoma in a pygmy goat [PDF]

open access: yes, 2016
A six-year-old, male pygmy goat was referred with a sudden onset of peripheral lymphadenopathy, which initially started as enlarged inguinal lymph nodes. Clinical examination showed swollen retropharyngeal, prescapular and inguinal lymph nodes. Serologic
Chiers, Koen   +6 more
core  

Spatio-Temporal Deep Learning Models for Tip Force Estimation During Needle Insertion

open access: yes, 2019
Purpose. Precise placement of needles is a challenge in a number of clinical applications such as brachytherapy or biopsy. Forces acting at the needle cause tissue deformation and needle deflection which in turn may lead to misplacement or injury. Hence,
Antoni, Sven-Thomas   +8 more
core  

A prospective adaptive utility trial to validate performance of a novel urine exosome gene expression assay to predict high-grade prostate cancer in patients with prostate-specific antigen 2-10ng/ml at initial biopsy [PDF]

open access: yes, 2018
BACKGROUND: Discriminating indolent from clinically significant prostate cancer (PCa) in the initial biopsy setting remains an important issue. Prospectively evaluated diagnostic assays are necessary to ensure efficacy and clinical adoption.
Andriole, Gerry   +12 more
core   +1 more source

Home - About - Disclaimer - Privacy